Skip to main content
bob_shrewsbury

Robert Shrewsbury

Associate Professor

Robert Shrewsbury, Ph.D.

Associate Professor


bob_shrewsbury

PHONE
(919) 962-0093
EMAIL
bob_shrewsbury@unc.edu
ADDRESS
Beard Hall 202B, School Of Pharmacy, CB# 7574, Chapel Hill, NC, 27599-7574
DOWNLOAD CV

Bob Shrewsbury received his BS in pharmacy from the University of Oklahoma in 1972 and his PhD from the University of Kentucky in 1977. His background training is in basic and applied biopharmaceutics and pharmacokinetics and in drug-interaction mechanisms. More recently, his research interests have focused on classroom and laboratory instructional methodologies using Web-based or technology-based formats. He has authored over 100 book chapters, numerous online education courses and continuing education seminars and national certification examination study guides for pharmacy professionals, pharmacy students and pharmacy technicians. He built and maintains an internationally utilized website for pharmacy compounding where 40 percent of the users are from outside the United States. He was elected as member of the USP Expert Committee on Compounding in 2010 and again in 2015, and 2020.

Research

Basic and applied biopharmaceutics and pharmacokinetics. Influence of internet based instruction on student learning.

Publications

Refereed Journal Articles

  • Darst E., Makhlouf T., Brannick E., Mitchell T., Shrewsbury R.: A Student-Led Elective Compounding Course to Provide Quality Improvement Feedback for a Required Compounding Course. American Journal of Pharmaceutical Education, accepted for publication, September, 2020.
  • Shrewsbury R.P. (contributing author, 6 chapters): The Pharmacy Technician, 7th Edition, Morton Publishing Co., Englewood, Colorado, 2020 (18 chapters, 700 pages).  A continuing title in the American Pharmacists Association’s Basic Pharmacy and Pharmacology Series. Also has an associated text, Workbook & Certification Review, 7th Edition, Englewood, Colorado, 2020 (300 pages).
  • Shrewsbury R.P.: Applied Pharmaceutics in Contemporary Compounding. 4th edition, Morton Publishing Co., Englewood, Colorado, 2020 (40 chapters, 610 pages).

  • Lee R.K., Shrewsbury R.P.: Comparison of observational evaluations and potency analyses to assess aseptic techniques of student compounders. American Journal of Pharmaceutical Education 83(9): Article 7338 (2019).
  • Darst E.C., Shrewsbury R.P.: The Impact of the Pharmacist’s Intervention on Patient Education and Dosing of Suspensions. American Journal of Pharmaceutical Education 83(5): Article 6781 (2019).

  • Jih J.S., Shrewsbury R.P.: Student Self-Analysis of Their Nonsterile Preparations and its Effect on Compounding Confidence American Journal of Pharmaceutical Education 82(10): Article 6473 (2018).
  • Yoo KY., Shrewsbury R.P. : Effect of Course Structure on the Accuracy of Nonsterile Compounded Preparations. American Journal of Pharmaceutical Education 82(9): Article 6463 (2018).

 

  • Park H.L., Shrewsbury R.P.: Student Evaluation of Online Pharmaceutical Compounding Videos. American Journal of Pharmaceutical Education 80(2): Article 30 (2016).
  • Shrewsbury R.P. (contributing author, 6 chapters): The Pharmacy Technician, 6th Edition, Morton Publishing Co., Englewood, Colorado, 2016 (18 chapters, 700 pages).  A continuing title in the American Pharmacists Association’s Basic Pharmacy and Pharmacology Series.  Also has an associated text, Workbook & Certification Review, 6th Edition, Englewood, Colorado, 2016 (294 pages).


  • Shrewsbury R.P.: Applied Pharmaceutics in Contemporary Compounding, 3rd Edition, Morton Publishing Co., Englewood, Colorado, 2015 (32 chapters, 475 pages).
  • Roark A., Anksorus H., Shrewsbury R.P.: Long-term Results of an Analytical Assessment of Student Compounded Preparations. American Journal of Pharmaceutical Education 78(9):Article 164 (2014).
  • Alford E., Shrewsbury R.: Impact of Required Versus Optional Remake of a Preparation on Pharmacy Students’ Compounding Accuracy. American Journal of Pharmaceutical Education 77(4):Article 73 (2013).
  • Shrewsbury R.P. (contributing author, 6 chapters, 35% of text): The Pharmacy Technician, 5th Edition, Morton Publishing Co., Englewood, Colorado, 2013 (594 pages).  A continuing title in the American Pharmacists Association’s Basic Pharmacy and Pharmacology Series.  Also has an associated text, Workbook & Certification Review, 5th Edition, Englewood, Colorado, 2013 (278 pages).
  • Shrewsbury R., Augustine S., Birnie C., Nagel K., Ray D., Ruble J., Scolaro K., Athay Adams J.: Assessment and Recommendations of Compounding Education in AACP Member Institutions. American Journal of Pharmaceutical Education 76(7): Article S9 (2012).
  • Robertson J.L., Shrewsbury R.P.: Video Teleconferencing in the Compounding Laboratory Component of a Dual-Campus Doctor of Pharmacy Program. American Journal of Pharmaceutical Education 75(9):Article 181 (2011).
  • Shrewsbury R.P. (contributing author, 6 chapters, 45% of text): The Pharmacy Technician, 4th Edition, Morton Publishing Co., Englewood, Colorado, 2010 (532 pages).  A continuing title in the American Pharmacists Association’s Basic Pharmacy and Pharmacology Series.  Also has an associated text, Workbook & Certification Review, 4th Edition, Englewood, Colorado, 2010 (246 pages).
  • Shrewsbury R.P.: Applied Pharmaceutics in Contemporary Compounding, 2nd Edition, Morton Publishing Co., Englewood, Colorado, 2008 (30 chapters, 288 pages).
  • Shrewsbury R.P. (contributing author, 6 chapters, 40% of text): The Pharmacy Technician, 3rd Edition, Morton Publishing Co., Englewood, Colorado, 2007 (455 pages).  A continuing title in the American Pharmacists Association’s Basic Pharmacy and Pharmacology Series.  Also has an associated text, Workbook & Certification Review, 3rd Edition, Englewood, Colorado, 2007 (232 pages).
  • Shrewsbury R.P. (contributing author, 6 chapters, 40% of text): The Pharmacy Technician, 2nd Edition, Morton Publishing Co., Englewood, Colorado, 2004 (424 pages).  A continuing title in the American Pharmacists Association’s Basic Pharmacy and Pharmacology Series.  Also has an associated text, Workbook & Certification Review, 2nd Edition, Englewood, Colorado, 2004 (232 pages).
  • Shrewsbury R.P.: Applied Pharmaceutics in Contemporary Compounding, 1st Edition, Morton Publishing Co., Englewood, Colorado, 2001 (19 chapters, 200 pages).
  • Shrewsbury R.P. (contributing author, 5 chapters, 35% of text): Basic Pharmacology, Morton Publishing Co., Englewood, Colorado, 2000 (450 pages).  A continuing title in the American Pharmaceutical Association’s Basic Pharmacy and Pharmacology Series.
  • Shrewsbury R.P.: A Hybrid CD-Internet Delivery System for Pharmaceutical Care Laboratory Instruction. North American Web 2000 International Meeting, http://naweb.unb.ca/2k/posters/Shrewsbury1.html (2000).


  • Shrewsbury R.P. (contributing author, 7 chapters, 52% of text): The Pharmacy Technician, 1st Edition, Morton Publishing Co., Englewood, Colorado, 1999 (376 pages).  A title in the American Pharmaceutical Association’s Basic Pharmacy and Pharmacology Series.  Also has an associated text, Workbook & Certification Review, Morton Publishing Co., Englewood, Colorado, 1999 (151 pages).
  • Hadzija B.W., Shrewsbury R.P.: Stability of Four Commercial Products Delivered by Mail Order. International Journal of Pharmaceutical Compounding 3:59-63 (1999).
  • Shrewsbury R.P., Deloatch K.H.: Accuracy in Prescriptions Compounded by Pharmacy Students. International Journal of Pharmaceutical Compounding 2:139-142 (1998).
  • Shrewsbury R.P., Johnson L.W., Oliver S.R.: Influence of Moderate Hemodilution with Fluosol or Normal Saline on Carbaryl Disposition in Sprague-Dawley Rats. Journal of Pharmacy and Pharmacology 49:236-240 (1997).
  • Wright L.N., Thorp Jr. J.M., Kuller J.A., Shrewsbury R.P., Ananth C., Hartmann K.: Transdermal Nicotine Replacement in Pregnancy: Maternal Pharmacokinetics and Fetal Effects. American Journal of Obstetrics and Gynecology 176:1090-1094 (1997).
  • Hadzija B.W., Shrewsbury R.P.: Atropine Overdose with a Suppository Formulation Containing Atropine Sulfate. International Journal of Pharmaceutical Compounding 1:271-273 (1997).
  • Hall M.E., Shrewsbury R.P., Chen S.Y., Elkins A.L., Burnham B.S., Spielvogel B.F., Hall I.H.: The Disposition and Tissue Distribution of Trimethylamine-(14C)-Carboxyborane and Trimethylamine-(14C)-Carboxymethoxyborane in CF1 Mice. Pharmaceutical Sciences 3:473-478 (1997).
  • Murphy M.E., Elkins A.L., Shrewsbury R.P., Sood A., Spielvogel B.F., Hall I.H.: The Effects of Amine-Carboxyborane Related Derivatives on UMR-106 Bone Metabolism. Metal-Based Drugs 3:31-47 (1996).
  • Hadzija B.W., Shrewsbury R.P.: Determination of Hydrocodone in Tussionexâ Extended-Release Suspension by High-Performance Liquid Chromatography (HPLC). Journal of Forensic Sciences 41:878-880 (1996).
  • Miller III M.C., Sood A., Spielvogel B.F., Shrewsbury R.P., Hall I.H.: The Pharmacological Activities of the Metabolites of N-[[(Trimethylamino)boryl]carbonyl]-L-Phenylalanine Methyl Ester. Metal Based Drugs 3:219-226 (1996).
  • Hadzija B.W., Shrewsbury R.P.: Two Basic Pharmacy Courses with Strong Experimental (Laboratory) Component. Journal of Pharmacy Teaching 5:41-50 (1996).
  • Miller III M.C., Shrewsbury R.P., Elkins A.L., Sood A., Spielvogel B.F., Hall I.H.: The Disposition, Tissue Distribution, and Cellular Transport of N-[[(Trimethylamino)boryl]carbonyl]-L-Phenylalanine Methyl Ester in CF1 Mice. Journal of Pharmaceutical Sciences 84:933-936 (1995).
  • Murphy M.E, Shrewsbury R.P., Sood A., Spielvogel B.F., Elkins A.L., Hall I.H.: The Relationship Between Cytokine Regulation and Anti-inflammatory Action of Amine-Carboxyborane in L929 Fibroblasts and IC-21 Macrophages. Metal-Based Drugs 2(5) 257-269 (1995).
  • Shrewsbury R.P., Wyrick S.D., Elkins A.L., Izydore R.A., Chen S.Y., Miller III M.C., Burnham B.S., Hall I.H.: Disposition of the Pharmacologically Active Compound [1-14C-Acetyl]-1-Acetyl-4-Phenyl-1,2,4-Triazolidine-3,5-Dione in CF1 Mice. Drug Investigation 7:275-281 (1994).
  • Shrewsbury R.P., Oliver S.R., White L.G.: The Effect of Moderate Hemodilution with Fluosol on Cytochrome P4502D6 Activity in the Rat. Artificial Cells, Blood Substitutes, and Immobilization Biotechnology 22:1237-1242 (1994).
  • Collier A.M., Goldstein G.M., Shrewsbury R.P., Davis S.M., Koch G.G., Zhang C.A., Benowitz N.L., Lewtas J., Williams R.W.: Cotinine Elimination and Its Use as a Biomarker in Young Children Involuntarily Exposed to Environmental Tobacco Smoke. Indoor Environment 3:353-359 (1994).
  • Burnham B.S., Hall I.H., Shrewsbury R.P., Hall E.S., Sood A., Spielvogel B.F.: Disposition and Distribution of the Cytidine Cyanoborane Adduct, [2-14C]-2’-Deoxycytidine-3N-cyanoborane in CF1 Mice. Drug Investigation 6:75-82 (1993).
  • Collier A.M., Goldstein G.M., Shrewsbury R.P., Davis S.M., Koch G.G., Zhang C.A., Benowitz N.L., Lewtas J., Williams R.W.: Cotinine Elimination Following ETS Exposure in Young Children as a Function of Age, Sex, and Race. Proceedings of the Sixth International Conference on Indoor Air Quality and Climate 1:669-674 (1993).
  • Hadzija B.W., Shrewsbury R.P.: Participation of Graduate Students in the Undergraduate Instruction of Pharmaceutics. Journal of Pharmacy Teaching 4:11-19 (1993).
  • Shrewsbury R.P., Hong D.D., White L.G., Gordon T.R.: The Effect of Moderate Hemodilution with Fluosol-DA or Hespan on the Nonmicrosomal Acetylation of Sulfamethazine in the Rat. Journal of Pharmacy and Pharmacology 44:84-88 (1992).
  • Shrewsbury R.P.: Acute Effects of Moderate Fluosol-DA Hemodilution on Hepatic Microsomal and Nonmicrosomal Metabolism in Rats. Biomaterials, Artificial Cells, and Immobilization Biotechnology 20:1037-1043 (1992).
  • Hall I.H., Wong O.T., Sood A., Sood C.K., Spielvogel B.F., Shrewsbury R.P., Morse K.W.: Hypolipidemic Activity in Rodents of Boron Analogs of Phosphonoacetates and Cyanoborane Adducts of Dialkyl Aminomethylphosphonates. Pharmacological Research 25:259-270 (1992).
  • Hall I.H., Wong O.T., Wyrick S.D., Simlot R., Shrewsbury R.P.: Disposition of the Hypolipidemic Agent, 6-Amino-2-mercapto-5-methylpyrimidine-4-carboxylic acid, in Sprague Dawley Rats. Journal of Pharmacy and Pharmacology 43:360-363 (1991).
  • Shrewsbury R.P.: Plasma Volumes, Blood Volumes, and Plasma Protein Concentrations After Moderate Hemodilution with Fluosol-DA or Normal Saline in the Rat. Journal of Pharmacy and Pharmacology 43:371-374 (1991).
  • Grippo A.A., Wyrick S.D., Lee K.H., Shrewsbury R.P., Hall I.H.: Disposition of an Antineoplastic Sesquiterpene Lactone,3H-Plenolin, in BDF1 Mice. Planta Medica 57:309-314 (1991).
  • Shrewsbury R.P., White L.G.: The Effect of Moderate Hemodilution with Fluosol-DA or Normal Saline on Acetaminophen Metabolism in the Rat. Experientia 46:213-217 (1990).
  • Shrewsbury R.P., White L.G.: Evaluation of Cytochrome P-450 Mediated Metabolism of Antipyrine in the Rat at Different Extents of Fluosol-DA Hemodilution. Research Communications in Chemical Pathology and Pharmacology 67:411-414 (1990).
  •  Collier A.M., Goldstein G.M., Shrewsbury R.P., Zhang C.A., Williams R.W.: Urine Cotinine Elimination Half-life in Young Children Exposed to Side-stream Cigarette Smoke. Proceedings of the Fifth International Conference on Indoor Air Quality and Climate, Vol. 2, 1990, pp. 195-200.
  • Shrewsbury R.P., White L.G.: The In Situ Absorption of Antipyrine as a Measure of Intestinal Blood Flow in Fluosol-DA Hemodiluted Rats. Journal of Pharmacy and Pharmacology 42:511-512 (1990).
  • Shrewsbury R.P., Hong D.D.: The Effect of Fluosol-DA and Hespan Hemodilution on S-Warfarin Elimination in the Rat. Journal of Pharmacy and Pharmacology 42:665-666 (1990).
  • Shrewsbury R.P., White L.G.: Effect of the Method of Fluosol-DA Administration on Antipyrine Disposition in the Rat. Journal of Pharmacy and Pharmacology 42:813-816 (1990).


  • Shrewsbury R.P., White L.G.: Failure to Detect Heparin in Plasma Containing Fluosol-DA Using an Analytical Kit. Clinica Chimica Acta 179:347-348 (1989).
  • Oswald C.B., Wyrick S.D., Chaney S.G., Shrewsbury R.P., Hall I.H.: Disposition of Cisplatin Derivatives 3H-Cis-1,2-Diaminocyclohexanedichloro-platinum (II) and 3H-Cis-1,2-Diaminocyclohexanemalonato-platinum (II) in BDF1 Mice. Research Communications in Chemical Pathology and Pharmacology 64:41-58 (1989).
  • Shrewsbury R.P., Oliver S.R., Anderson W.T., Lewis L.M., White L.G.: The Effect of Varying Percentages of Fluosol-DA Hemodilution on Antipyrine Metabolism in the Rat. in: Hanker J.S., Giammara B.L. (editors) Biomedical Materials andDevices, Materials Research Society Symposium Proceedings, Vol. 110, Materials Research Society, Pittsburgh, PA., 1989, pp. 147-151.
  • Hall I.H., Oswald C.B., Wyrick S.D., Maguire J.H., Shrewsbury R.P.: Disposition of the Hypolipidemic Agent, 14C-2,3-Dihydrophthalazine-1,4-dione, in Sprague Dawley Rats. Journal of Pharmacy and Pharmacology 41:394-397 (1989).
  • Shrewsbury R.P., White L.G.: The Effect of Moderate Fluosol-DA Hemodilution on Gender Specific Metabolism of Antipyrine. Research Communications in Chemical Pathology and Pharmacology 64:455-462 (1989).
  • Shrewsbury R.P., Oliver S.R., Lewis L.M., Anderson W.T., White L.G.: The Effect of Varying Extents of Fluosol-DA or Normal Saline Hemodilution on the Dose Dependent Kinetics of Phenytoin in the Rat. Journal of Pharmacy and Pharmacology 41:582-584 (1989).
  • Shrewsbury R.P., Oliver S.R., White L.G.: The Effect of Moderately Severe Hemodilution with Fluosol-DA on Cytochrome P-450 Mediated Antipyrine Metabolism. Biomaterials, Artificial Cells, and Artificial Organs 17:393-402 (1989).
  • Shrewsbury R.P., White L.G.: Some Insights into the Variations in Antipyrine Pharmacokinetics in the Rat. Research Communications in Chemical Pathology and Pharmacology 62:137-140 (1988).
  • Shrewsbury R.P., Oliver S.R., Anderson W.T., Lewis L.M., White L.G.: The Effect of Varying Percentages of Hemodilution with Fluosol-DA and Normal Saline of Antipyrine Metabolism in the Rat. Journal of Pharmacy and Pharmacology 40:392-398 (1988).
  • Shrewsbury R.P., Oliver S.R., Lewis L.M., Anderson, W.T.: Effect of Different Hemodilution Percentages with Fluosol-DA or Normal Saline on Antipyrine Kinetics in the Rat. Biomaterials, Artificial Cells, and Artificial Organs 16:695-697 (1988). Also in: Chang T.M.S., Geyer R.P. (editors) Blood Substitutes, Marcel Dekker, New York, 1989, pp. 695-697.
  • Hall I.H., Reynolds D.J., Wyrick S.D., Maguire J.H., Shrewsbury R.P.: The Disposition of the Hypolipidemic Agent, 14C-o-(N-phthalimido)acetophenone, in Sprague Dawley Rats. Drug Disposition and Metabolism 16:196-200 (1988).
  • Shrewsbury R.P., Lewis L.M., Oliver S.R., Womble C.L.: Effect of Moderate Hemodilution with Fluosol-DA or Normal Saline on Indocyanine Green and (+)-Propranolol Kinetics. Journal of Pharmacy and Pharmacology 39:592-598 (1987).
  • Shrewsbury R.P., Lewis L.M., Oliver S.R.: Effect of Moderate Hemodilution with Fluosol-DA or Normal Saline on Low-Dose Phenytoin and (±)-5-(4-hydroxyphenyl)-5-phenylhydantoin Kinetics. Journal of Pharmacy and Pharmacology 39:349-356 (1987).
  • Shrewsbury R.P.: Effect of Fluosol-DA Hemodilution on the Kinetics of Hepatically Eliminated Drugs. Research Communications in Chemical Pathology and Pharmacology 55:375-396 (1987).
  • Merritt J.C., Shrewsbury R.P., Locklear F., Demby K.B., Wittle G.L.: Effects of D9-Tetrahydrocannabinol and Vehicle Constituents on Intraocular Pressure in Normotensive Dogs. Research Communications in Substances of Abuse 7:29-35 (1986).
  • Shrewsbury R.P., White S.G., Pollack G.M., Wargin W.A.: Antipyrine Kinetics Following Partial Blood Exchange with Fluosol-DA in the Rat. Journal of Pharmacy and Pharmacology 38:883-887 (1986).
  • Shrewsbury R.P.: Effect of Moderate Hemodilution with Fluosol-DA or Normal Saline on Ampicillin Kinetics. Journal of Pharmacy and Pharmacology 38:647-652 (1986).
  • Shrewsbury R.P., Swarbrick J., Newton K.S., Riggs L.C.: Influence of Ophthalmic Formulations on Sodium Cromoglycate Disposition in the Albino Rabbit Eye. Journal of Pharmacy and Pharmacology 37:614-617 (1985).
  • Shinn A.F., Shrewsbury R.P.: Evaluations of Drug Interactions, 3rd edition. C.V. Mosby Co., St. Louis, Missouri, 1985 (783 pages).  A title of the American Pharmaceutical Association.
  • Gural R.P., Chungi V.S., Shrewsbury R.P., Dittert L.W.: Dose Dependent Absorption of Disodium Etidronate. Journal of Pharmacy and Pharmacology 37:443-445 (1985).
  • Shrewsbury R.P., Wurster D.E., Dittert L.W.: Dose Dependent Effect of Calcium and Magnesium Etidronate on Salicylic Acid Absorption in the Rat. Journal of Pharmacy and Pharmacology 37:440-442 (1985).
  • Swarbrick J., Shrewsbury R.P.: The Prolonged Retention of Sodium Cromoglycate in the Rabbit Eye. Journal of Pharmacy and Pharmacology 36:121-122 (1984).
  • Shinn A.F., Shrewsbury R.P., Anderson K.A.: Development of a Computerized Drug Information Database (Medicom®) for Use in a Patient Specific Environment. Drug Information Journal 17:205-210 (1983).
  • Shrewsbury R.P., Metcalf T.B., Weiss D.L., Dittert L.W.: Influence of Disodium Etidronate on the Absorption of Salicylic Acid in the Rat. Journal of Pharmacy and Pharmacology 34:823-825 (1982).
  • Wurster D.E., Shrewsbury R.P.: Simulation Package for Multiple Intravenous Infusions of Two Compartment Pharmacokinetic Drugs. International Journal of Bio-Medical Computing 12:455-470 (1981).
  • Hieb B.R., Shrewsbury R.P.: Consecutive Intravenous Infusions: Simulations of Two Compartment Pharmacokinetic Drugs. Computer Programs in Biomedicine 12:96-104 (1980).
  • Shrewsbury R.P., Foster T.S., Dittert L.W., Quigley J.W., Leavell U.M.: Percutaneous Absorption of Hydroxyurea Through Psoriatic Lesions. Current Therapeutic Research 28:1002-1011 (1980).
  • Foster T.S., Shrewsbury R.P., Coonrod J.D.: Bioavailability and Pain Study of Cefamandole Nafate. Journal of Clinical Pharmacology 20:526-533 (1980).


Nonrefereed Journal Articles


  • Shrewsbury R.P.: University of North Carolina at Chapel Hill School of Pharmacy Pharmaceutical Care Laboratories: Compounding Laboratory Curriculum and Renovation. International Journal of Pharmaceutical Compounding 10:353-358 (2006).


  • Shinn A.F., Shrewsbury R.P.: The Drug Interaction Dilemma. Computertalk Directory of Pharmacy Systems-1983. 34:39 (1983).


Abstracts


  • Dinkins L., Shrewsbury R.: Duplicating a Well-Controlled Stability Research Study in a Teaching Compounding Laboratory. Abstracts of the 115th Annual Meeting of the American Association of Colleges of Pharmacy. Dallas, Texas (2014). American Journal of Pharmaceutical Education 78:5 (2014).
  •  Shrewsbury R., Park H.: Evaluation of Pharmaceutical Compounding Videos. Abstracts of the 115th Annual Meeting of the American Association of Colleges of Pharmacy. Dallas, Texas (2014). American Journal of Pharmaceutical Education 78:5 (2014).


  • Anksorus H., Shrewsbury R.: The Long-Term Benefit Of The Analysis Requirement In Assessing Student Compounded Preparations. Abstracts of the 114th Annual Meeting of the American Association of Colleges of Pharmacy, Chicago, Illinois (2013).


  • Shrewsbury R.: Using an Analysis Requirement for Assigning Compounded Product Grades: Required or Optional Re-Makes? Abstracts of the 112th Annual Meeting of the American Association of Colleges of Pharmacy. San Antonio, Texas (2011).
  • 33. Shrewsbury R.: Compounding in Schools of Pharmacy: A Report of the AACP COS Task Force on Compounding. Abstracts of the 112th Annual Meeting of the American Association of Colleges of Pharmacy. San Antonio, Texas (2011).

  • Shrewsbury R.: An Analysis Requirement for Compounded Products. Is It Worth It? Abstracts of the 111th Annual Meeting of the American Association of Colleges of Pharmacy. Seattle, Washington (2010).


  • Robertson J., Shrewsbury R.: Conducting a Pharmaceutical Care Laboratory (PCL) Compounding Course via Video Teleconferencing.  Abstracts of the 110th Annual Meeting of the American Association of Colleges of Pharmacy, Boston,Massachusetts. American Journal of Pharmaceutical Education 73:68 (2009).


  • Stegall-Zanation J., White-Harris C., Shrewsbury R., Reuning S.: A DVD Demonstration Tool to Enhance Knowledge of Curricular Courses. Abstracts of the 106th Annual Meeting of the American Association of Colleges of Pharmacy, Cincinnati, Ohio. American Journal of Pharmaceutical Education 69:404 (2005).

  • Shrewsbury R.P.: A Hybrid CD-Internet Delivery System for Pharmaceutical Care Laboratory Instruction. Abstracts of the 101st Annual Meeting of the American Association of Colleges of Pharmacy, San Diego, California. American Journal of Pharmaceutical Education 64, No. 4 Supplement:106S (2000).
  • Shrewsbury R.P., Deloatch K.H.: Lecture Outcome – Cape Outcome Review (LOCOR) Project. Abstracts of the 101stAnnual Meeting of the American Association of Colleges of Pharmacy, San Diego, California. American Journal of Pharmaceutical Education 64, No. 4 Supplement:104S (2000).
  • Pittman A.W., Shrewsbury R.P., Bastow K.F., Campbell W.H., Christensen D.B., Dell K.A., Deloatch K.H., Joyner P.U., Raasch R.H.: A CD-ROM/Web-Based ACPE Self Study. Abstracts of the 101st Annual Meeting of the American Association of Colleges of Pharmacy, San Diego, California. American Journal of Pharmaceutical Education 64, No. 4 Supplement:103S (2000).


  • Pulliam C.C., Joyner P.U., Shrewsbury R., Carson S.W., Pittman A.W., Vaisman I.: World Wide Web Applications to Benefit Distance Learning in an External Doctor of Pharmacy Program. Abstracts of the 98th Annual Meeting of the American Association of Colleges of Pharmacy, Indianapolis, Indiana, p. 37 (1997).
  • Hadzija B.W., Shrewsbury R.P.: Two Basic Pharmacy Courses with Strong Experimental (Laboratory) Components. Abstracts of the 97th Annual Meeting of the American Association of Colleges of Pharmacy, Reno, Nevada, p. 148 (1996).
  • Ely J.G., Hall I.H., Elkins A.L., Shrewsbury R.P.: Transepithelial Transport of Boronated Dipeptides Across a Cell Model: HCT-8. Abstracts of the 142nd Annual Meeting of the American Pharmaceutical Association, Orlando, Florida (1994).
  • Sood A., Spielvogel B.F., Hall I.H., Cho M.J., Shrewsbury R.P., Powell W.J., Karthikeyan S., Miller III M.C., Elkins A.L.: Amine-carboxyboranes (Analogs of a-Amino Acids): Building Blocks for New Peptide Libraries. Abstracts of the Molecular Diversity Symposium, North Carolina Biotechnology Center, Research Triangle Park, North Carolina, pp. 14-15 (1994).
  • Shrewsbury R.P., Izydore R.A., Hall I.H.: 1-Acetyl-4-phenyl-1,2,4-triazolidine-3,5-dione. Drug Data Reports 17:393 (1993).
  • Elkins A.L., Cho M., Shrewsbury R.P., Sood A., Spielvogel B.F., Hall I.H., Miller III M.C.: Cellular Uptake and Tissue Disposition of Trimethylamine Carboxyborane-phenylalanine Methyl Ester in CF1 Mice and L-1210 Lymphoid Cells. Abstracts of the 8th International Meeting in Boron Chemistry, Knoxville, Tennessee (1993).
  • Hall I.H., Rajendran K.G., Chen S.Y., Burnham B.S., Murphy M.E., Shrewsbury R.P., Sood A., Spielvogel B.F., Morse K.W., Norwood III V.M.: Anti-inflammatory Activity and Cytokine Modulation of Trimethylamine Carboxyboranes and Related Derivatives. Abstracts of the 8th International Meeting in Boron Chemistry, Knoxville, Tennessee (1993).
  • Shrewsbury R.P., Oliver S.R., White L.G.: The Effect of Moderate Fluosol-DA Hemodilution on Desipramine Pharmacokinetics in the Rat. Abstracts of the 5th International Symposium on Blood Substitutes, San Diego, California, p. F38 (1993).
  • Collier A.M., Goldstein G.M., Shrewsbury R.P., Zhang C.A., Benowitz N.L., Williams R., Lewtas J.: Cotinine Elimination in Young Children as a Function of Age, Sex, and Race Following ETS Exposure. American Reviews of Respiratory Disease 145 (No. 4 Suppl., part 2):A532 (1992).
  • Shrewsbury R.P., White L.G.: Acute Effects of Moderate Fluosol-DA Hemodilution on Hepatic Microsomal and Nonmicrosomal Metabolism in Rats. Biomaterials, Artificial Cells, and Immobilization Biotechnology 19:485 (1991).
  • Shrewsbury R., Hong D., White L., Gordon T.: The Effect of Moderate Fluosol-DA or Hespan Hemodilution on the Nonmicrosomal Acetylation of Sulfamethazine in the Rat. Pharmaceutical Research 8(No. 10 Suppl.):234 (1991).
  • Burnham B.S., Wyrick S.D., Shrewsbury R.P., Shaw B.R., Sood A., Spielvogel B.F., Hall I.H.: Radiolabelled Synthesis of [2-14C]-2′-Deoxycytidine-3N-cyanoborane, Tissue Disposition in Mice, and Antineoplastic Mode of Action in T-Molt Leukemic Cells. Abstracts of the Boron USA Workshop (BUSA II), Research Triangle Park, North Carolina, p. 63 (1990).
  • Shrewsbury R., White L.: Influence of the Method of Fluosol-DA Administration on Antipyrine Metabolism in the Rat. Pharmaceutical Research 7(No. 9 Suppl.):S262 (1990).


  • Shrewsbury R.P., White L.G.: The Effect of Moderate Hemodilution with Fluosol-DA or Normal Saline on Acetaminophen Metabolism in the Rat. Pharmaceutical Research 6(No. 9 Suppl.):S205 (1989).
  • Shrewsbury R., Oliver S., White L.: Effect of Varying Percentages of Hemodilution with Fluosol-DA or Normal Saline on Indocyanine Green and d-Propranolol Disposition in the Rat. Pharmaceutical Research 5(No. 10 Suppl.):S194 (1988).
  • Shrewsbury R.P., Oliver S.R., Lewis L.M., Anderson W.T., White L.G.: The Effect of Varying Percentages of Hemodilution With Fluosol-DA and Normal Saline on Antipyrine Metabolism in the Rat. Journal of Pharmaceutical Sciences 76:S96 (1987). Also in the Abstracts of the 1987 Fall Meeting of the Materials Research Society, Boston, Massachusetts, p. 347 (1987).
  • Shrewsbury R.P., Lewis L.M., Oliver S.R., Womble C.L.: Indocyanine Green and d-Propranolol Kinetics Following Moderate Fluosol-DA or Normal Saline Hemodilution. Pharmaceutical Research 4(No. 2 Suppl.):S119 (1987).
  • Shrewsbury R.P., Oliver S.R., Lewis L.M.: Dose Dependent Effect of Fluosol-DA and Normal Saline Hemodilution on Antipyrine Kinetics in the Rat. Biomaterials, Artificial Cells, and Artificial Organs 15:662 (1987).
  • Shrewsbury R.P.: Ampicillin Kinetics Following Partial Fluosol-DA or Normal Saline Blood Exchange. Abstracts of the 133rd Annual Meeting of the American Pharmaceutical Association, San Francisco, California, 16:127 (1986).
  • Shrewsbury R.P., Lewis L.M., Oliver S.R.: Phenytoin Kinetics Following Partial Fluosol-DA or Normal Saline Blood Exchange. Pharmaceutical Research 3(No. 5 Suppl.):161S (1986).
  • Shrewsbury R.P., Dorr M.B., Pollack G.M.: Effects of Anesthesia and Blood Replacement on Antipyrine Kinetics in Rats. Abstracts of the 38th National Meeting of the Academy of Pharmaceutical Sciences, San Antonio, Texas, 15:111 (1985).
  • Grippo A.A., Wyrick S.D., Shrewsbury R.P., Chaney S.G., Holbrook D.J., Lee K.H., Hall I.H.: The Disposition of (3H)-11,13-Dihydrohelenalin, a Derivative of the Sesquiterpene Lactone Helenalin. Pharmacologist 27:109 (1985).
  • Reynolds D.J., Wyrick S.D., Shrewsbury R.P., Hall I.H.: The Metabolic Disposition of the Hypolipidemic Agent o-(N-Phthalimido)acetophenone in Rodents. Pharmacologist 27:211 (1985).
  • White S.G., Wargin W.A., Shrewsbury R.P.: Antipyrine Kinetics Following Perfluorochemical (PFC) Emulsion-Blood Exchange. Abstracts of the 37th National Meeting of the Academy of Pharmaceutical Sciences, Philadelphia, Pennsylvania, 14:232 (1984).
  • Shrewsbury R.P., Swarbrick J., Newton K.S., Riggs L.C.: The Retention of Topically Applied Sodium Cromoglycate in the Albino Rabbit Eye. Abstracts of the 36th National Meeting of the Academy of Pharmaceutical Sciences, Montreal, Canada, 14:69 (1984).
  • Shrewsbury R.P., Wurster D.E., Dittert L.W.: Dose Dependent Effect of Disodium Etidronate on Salicylic Acid Absorption in the Rat. Abstracts of the 33rd National Meeting of the Academy of Pharmaceutical Sciences, San Diego, California, 12:170 (1982).


Books


  • Shrewsbury R.P.: Applied Pharmaceutics in Contemporary Compounding, 3rd Edition, Morton Publishing Co., Englewood, Colorado, 2015 (464 pages).


  • Shrewsbury R.P. (contributing author, 6 chapters, 35% of text): The Pharmacy Technician, 5th Edition, Morton Publishing Co., Englewood, Colorado, 2013 (594 pages).  A continuing title in the American Pharmacists Association’s Basic Pharmacy and Pharmacology Series. Also has an associated text, Workbook & Certification Review, 5th Edition, Englewood, Colorado, 2013 (278 pages).


  • Shrewsbury R.P. (contributing author, 6 chapters, 45% of text): The Pharmacy Technician, 4th Edition, Morton Publishing Co., Englewood, Colorado, 2010 (532 pages).  A continuing title in the American Pharmacists Association’s Basic Pharmacy and Pharmacology Series.  Also has an associated text, Workbook & Certification Review, 4th Edition, Englewood, Colorado, 2010 (246 pages).


  • Shrewsbury R.P.: Applied Pharmaceutics in Contemporary Compounding, 2nd Edition, Morton Publishing Co., Englewood, Colorado, 2008 (288 pages).

  • Shrewsbury R.P. (contributing author, 6 chapters, 40% of text): The Pharmacy Technician, 3rd Edition, Morton Publishing Co., Englewood, Colorado, 2007 (455 pages).  A continuing title in the American Pharmacists Association’s Basic Pharmacy and Pharmacology Series.  Also has an associated text, Workbook & Certification Review, 3rd Edition, Englewood, Colorado, 2007 (232 pages).


  • Shrewsbury R.P. (contributing author, 6 chapters, 40% of text): The Pharmacy Technician, 2nd Edition, Morton Publishing Co., Englewood, Colorado, 2004 (424 pages).  A continuing title in the American Pharmacists Association’s Basic Pharmacy and Pharmacology Series.  Also has an associated text, Workbook & Certification Review, 2nd Edition, Englewood, Colorado, 2004 (232 pages).


  • Shrewsbury R.P.: Applied Pharmaceutics in Contemporary Compounding, Morton Publishing Co., Englewood, Colorado, 2001 (200 pages).

  • Shrewsbury R.P. (contributing author, 35% of text): Basic Pharmacology, Morton Publishing Co., Englewood, Colorado, 2000 (450 pages).  A continuing title in the American Pharmaceutical Association’s Basic Pharmacy and Pharmacology Series.


  • Shrewsbury R.P. (contributing author, 52% of text): The Pharmacy Technician, Morton Publishing Co., Englewood, Colorado, 1999 (376 pages).  A title in the American Pharmaceutical Association’s Basic Pharmacy and Pharmacology Series.  Also has an associated text, Workbook & Certification Review, Morton Publishing Co., Englewood, Colorado, 1999 (151 pages).


  • Shinn A.F., Shrewsbury R.P.: Evaluations of Drug Interactions, 3rd edition. C.V. Mosby Co., St. Louis, Missouri, 1985 (783 pages).  A title of the American Pharmaceutical Association.


Book Chapters


  • Shrewsbury R.P.: Pharmaceutical and Medicinal Monographs for Diuretic Drugs. Remington: The Science and Practice of Pharmacy, 22nd edition. Pharmaceutical Press, London, 2012.


Book Reviews


  • Shrewsbury R.P.: Modern Pharmaceutics, 4th Edition, Marcel Dekker, New York, 2002. American Journal of Pharmaceutical Education 66:468-469 (2002).


  • Shrewsbury R.P.: Remington: The Science and Practice of Pharmacy, 20th Edition, Lippincott Williams & Wilkins, Baltimore, 2000. American Journal of Pharmaceutical Education 65:304 (2001).


  • Shrewsbury R.P.: Blood Substitutes: Preparation, Physiology and Medical Applications, Lowe K.C. (ed.), VCH Publishers, New York, 1988. American Journal of Pharmaceutical Education 53:464 (1989).


Other Publications


  • Shinn A.F. (editor), Shrewsbury R.P. (associate editor): Medicomsm Drug Information Newsletter (published monthly), Professional Drug Systems, Inc., St. Louis, Missouri, 1983-1984.
  • Shrewsbury R.P.: Continuing Education in Biopharmaceutics and Pharmacokinetics, correspondence course for practicing pharmacists, through the C.E. Division of the St. Louis College of Pharmacy, St. Louis, Missouri, 1980-1986.


  • Shinn A.F. (editor), Shrewsbury R.P. (associate editor): Drug Information Center Newsletter (published monthly), St. Louis College of Pharmacy, St. Louis, Missouri, 1977-1978.


CD-ROMS


  • Pittman A.W., Shrewsbury R.P., Bastow K.F., Campbell W.H., Christensen D.B., Dell K.A., Deloatch K.H., Joyner P.U., Raasch R.H., Early M.E.: Self-Study Report for the Doctor of Pharmacy Curriculum, University of North Carolina School of Pharmacy (1999).
  • Shrewsbury R.P.: Pharmaceutical Laboratory Learning CD, University of North Carolina School of Pharmacy (1999).


Online Materials


  1. Pharmaceutical Laboratory Web Site (http://pharmlabs.unc.edu). A web resource for Doctor of Pharmacy level courses in Compounding and Pharmaceutics, 1996-present.  The site has been listed as a Basic Resource for Pharmaceutical Education by the American Association of Colleges of Pharmacy since 1999. The site averages 1,500 visitors/month, with 40% of visitors from outside the United States.
  2. Advanced Pharmaceutical Compounding. A Doctor of Pharmacy level course, Professional Compounding Centers of America, Inc., Houston, Texas, 2003-present, Version 2.0, 2009.
  3. Pharmacy Licensure Review (PLR). A study module for Doctor of Pharmacy students to prepare for the national pharmacy licensure examination (NAPLEXÓ), Professional Compounding Centers of America, Inc., Houston, Texas, 2002-2008.
  4. Dosage Forms and Drug Delivery Systems (I and II). A Doctor of Pharmacy level course, Professional Compounding Centers of America, Inc., Houston, Texas, 2000-2006.
  5. The Medicomâ Family of Medical Information Databases for Retail and Hospital Pharmacies, Professional Drug Systems, Inc., St. Louis, Missouri, 1978-1985.  A pharmacy managerial system plus drug-drug, drug-food, drug-OTC, drug-IV incompatibility, drug-allergy, and drug-chronic disease interaction databases.  Utilized by:
  • Retail Pharmacy – Medicare Glaser Corp. of St. Louis and Giant Foods Corp. of Washington, DC (licensed in 1983).
  • Hospital Pharmacy – McDonnell Douglas Automation (McAuto®) which provided computer services to one out of six hospitals in the nation (licensed in1983).
  • Physician Private Practice – Compunet®, a computer system for physicians (licensed in 1983).


Presentations

 

  • USP Second Annual Workshop: Evolution and Advances in Compounding: Evolution of Pharmaceutical Dosage Forms – What is on the Horizon for Compounders? USP, Washington Aug 6, 2019
  • The National Academies of Sciences, Engineering, Medicine, Health and Medicine Division, Board of Health Sciences Policy, Assessment of the Available Scientific Data Regarding the Safety and Effectiveness of Ingredients Used in Compounded Topical Pain Creams Study Sponsor Food and Drug Administration  May 20, 2019  Background on the Curriculum and Training for Compounding Pharmacists

  • “An Update on USP <795> and <797> Revisions,” 2018 NABP District III Meeting, Asheville, North Carolina, August 2018.
  • “Open Microphone Session on USP General Chapter <795> Pharmaceutical Compounding—Nonsterile Preparations” USP Headquarters, Washington, D.C., April 2018.

 

 


  • “Pharmaceutical Calculations for Pharmacy Technicians,” 2015 NCAP Annual Convention, Raleigh, North Carolina, November 2015.
  • “Pharmaceutical Calculations for Pharmacy Technicians,” 2014 NCAP Annual Convention, Raleigh, North Carolina, October 2014.
  • “Overview of Compounding in Today’s Environment,” 29th Annual Pharmacy Practice Seminar, Wilmington, North Carolina, August, 2014.
  • “Overview of Compounding in Today’s Environment,” 2013 NCAP Annual Convention, Raleigh, North Carolina, October, 2013.
  • “Building Web-based Classroom Resources on a Budget,” Pre-conference Workshop, 12th International Conference of the Society for Information Technology and Teacher Education (SITE 2001), Orlando, Florida, March 2001.
  • “Doing IT on a $8,000 Budget,“ Pre-conference Workshop, The Community College Foundation (TechEd01), Ontario, California, March 2001.
  • “Lessons in Creating and Integrating Instructional Multimedia,” Carolina Technology Expo 2000, Chapel Hill, North Carolina, March 2000.

  • “Using a CD-Internet Hybrid Delivery System for Multimedia Learning,” Carolina Technology Expo ’99, Chapel Hill, North Carolina, February 1999.
  • “Teaching Pharmaceutics on the Web,” 99th Annual Meeting of the American Association of Colleges of Pharmacy, Boston, Massachusetts, July 1998.
  • “Acute Effects of Moderate Fluosol-DA Hemodilution on Hepatic Microsomal and Nonmicrosomal Metabolism in Rats,” IV International Symposium on Blood Substitutes, Montreal, Canada, August 1991.


  • “The Effect of Fluosol-DA Hemodilution on Hepatic Microsomal and Nonmicrosomal Metabolism,” Letterman Army Institute of Research, USAMRDC, Presidio of San Francisco, California, December 1989.
  • “The Effect of Perfluorochemical Emulsion Hemodilution on Cytochrome P-450 Activity in the Rat,” Wayne State University, Department of Physiology, Detroit, Michigan, December 1988.
  • “The Effect of Varying Percentages of Fluosol-DA Hemodilution on Antipyrine Metabolism in the Rat,” 1987 Fall Meeting of the Materials Research Society, Boston, Massachusetts, December 1987.
  • “Effect of Fluosol-DA Hemodilution on the Kinetics of Hepatically Extracted Drugs,” Pharmaceutical Sciences Post-Graduate Research Conference, University of Kentucky College of Pharmacy, Lexington, Kentucky, October 1986.
  • “Workshop on Drug Product Selection,” Area Health Education Center (AHEC), Albemarle Hospital, Elizabeth City, North Carolina, November 1986.
  • “Drug Product Selection Using Bioavailability Data,” Area Health Education Center (AHEC), Wilson Memorial Hospital, Wilson, North Carolina, November 1986.
  • “Influence of Fluosol-DA on Antipyrine Kinetics in Blood Exchanged Rats,” Pharmaceutical Sciences Post-Graduate Research Conference, University of Kentucky College of Pharmacy, Lexington, Kentucky, October 1984.
  • “The Retention of Topically Applied Sodium Cromoglycate in the Albino Rabbit Eye,” 36th National Meeting of the Academy of Pharmaceutical Sciences, Montreal, Canada, May 1984.
  • “Criteria for Drug Product Selection,” Area Health Education Center (AHEC), New Hanover Memorial Hospital, Wilmington, North Carolina, March 1984.
  • “Bioavailability Data in Drug Product Selection,” Northwest Area Health Education Centers (AHEC), Bowman Gray School of Medicine and Catawba Memorial Hospital, Winston-Salem and Hickory, North Carolina, October 1983.
  • “Dose Dependent Effect of Disodium Etidronate on Salicylic Acid Absorption in the Rat,” 33rd National Meeting of the Academy of Pharmaceutical Sciences, San Diego, California, November 1982.


  • “Basic Pharmacokinetics: A Continuing Education Program for Practicing Pharmacists,” St. Louis, Missouri, October-November 1979.
  • “Monitoring Drug Therapy with Pharmacokinetic Parameters,” The Jewish Hospital of Washington University, Department of Medicine, St. Louis, Missouri, November 1979.
  • “Changes in Pharmacokinetic Parameters During Pregnancy,” The Jewish Hospital of Washington University, Department of Obstetrics and Gynecology, St. Louis, Missouri, October 1979.
  • “Influence of Disodium Etidronate on the Absorption of Model Compounds,” University of North Carolina School of Pharmacy, Chapel Hill, North Carolina, March 1979.
  • “Absorption of Disodium Etidronate in the Rat, In Situ,” Butler University School of Pharmacy, Indianapolis, Indiana, October 1978.
  • “Bioavailability Considerations of Theophylline and Related Drugs,” St. Louis College of Pharmacy, St. Louis, Missouri, April 1977.
  • “Percutaneous Absorption of Hydroxyurea in Psoriatic Patients,” Ferris State University School of Pharmacy, Big Rapids, Michigan, November 1976.


Bob Shrewbury News